Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Revenue (2020 - 2022)

RAPT Therapeutics' Revenue history spans 3 years, with the latest figure at $886000.0 for Q2 2022.

  • For Q2 2022, Revenue rose 1.96% year-over-year to $886000.0; the TTM value through Mar 2023 reached $886000.0, down 72.59%, while the annual FY2022 figure was $1.5 million, 59.95% down from the prior year.
  • Revenue for Q2 2022 was $886000.0 at RAPT Therapeutics, up from $641000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.5 million in Q3 2020 and bottomed at $641000.0 in Q1 2022.
  • The 3-year median for Revenue is $950500.0 (2020), against an average of $1.0 million.
  • The largest annual shift saw Revenue soared 30.7% in 2021 before it tumbled 47.55% in 2022.
  • A 3-year view of Revenue shows it stood at $1.3 million in 2020, then tumbled by 41.94% to $756000.0 in 2021, then grew by 17.2% to $886000.0 in 2022.
  • Per Business Quant, the three most recent readings for RAPT's Revenue are $886000.0 (Q2 2022), $641000.0 (Q1 2022), and $756000.0 (Q4 2021).